anti-MAPK6 Antibody from antibodies-online

Supplier Page

Supplier Page from
antibodies-online for
anti-MAPK6 Antibody

Description

Product Characteristics:
Mitogen-activated protein kinase (MAPK) signaling pathways involve closely related MAP kinases, including extracellular-signal-related kinase 3 (ERK 3, also designated PRKM6 and p97MAPK). Serum, growth factors and phorbol esters can initiate ERK 3 signaling pathways. Despite lacking a definitive nuclear localization sequence, ERK 3 constitutively localizes to the nucleus upon activation. p38 pathway activation-dependent upregulation of ERK 3 is independent of the status of p53, Bcl-2 and caspase-3 during cell stress and damage induced by proteasome inhibition, suggesting ERK 3 in part mediates intracellular defense or cell rescue. The human ERK 3 gene maps to chromosome 15q21.2 and encodes a 721 amino acid protein.

Subcellular location: Cytoplasm, Nucleus

Synonyms: ERK-3, ERK3, ERK 3, ERK-3, Extracellular signal regulated kinase 3, Extracellular signal regulated kinase p97, Extracellular signal-regulated kinase 3, MAP kinase 6, MAP kinase isoform p97, MAPK 6, MAPK6, Mitogen activated protein kinase 6, Mitogen-activated protein kinase 6, MK06_HUMAN, p97 MAPK, p97-MAPK, PRKM6, Protein kinase mitogen activated 5, Protein kinase mitogen activated 6.

Target Information: The protein encoded by this gene is a member of the Ser/Thr protein kinase family, and is most closely related to mitogen-activated protein kinases (MAP kinases). MAP kinases also known as extracellular signal-regulated kinases (ERKs), are activated through protein phosphorylation cascades and act as integration points for multiple biochemical signals. This kinase is localized in the nucleus, and has been reported to be activated in fibroblasts upon treatment with serum or phorbol esters. [provided by RefSeq, Jul 2008]